Ignite Creation Date:
2024-05-05 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00343720
Status:
COMPLETED
Last Update Posted:
2008-03-13
First Post:
2006-06-22
Brief Title:
Study of Alimta Pemetrexed Plus VELCADE Bortezomib or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy
Sponsor:
Organization:
Millennium Pharmaceuticals Inc